Return to Home Page
 

Site Map

Home
Home Page

Blood Safety
Blood Safety Introduction
Bacteria
New & Emerging Pathogens
Other Known Pathogens
Window Period Limitation
Leukocytes
Bibliography

Product Overview
A Single Solution
INTERCEPT Platelets
INTERCEPT Plasma

Pharmaceutical Standards
Mechanism of Action
Scientific Publications: Recent
PI & Blood Safety
INTERCEPT Platelets
Journal Articles
Conference Abstracts
INTERCEPT Plasma
Journal Articles
Conference Abstracts
News & Events
2009 Webinars
ISBT Cairo 2009 Symposium
EHS Rome 2009 Workshop
AABB Montreal 2008 Workshop
ISBT Macao 2008 Symposium

 

Technical Information
Technical Information Overview
Instructions for Use
INTERCEPT Blood System Technical Data Sheets
INTERCEPT Platelets Product Description
Indications and Contraindications
Viruses
Bacteria
Parasites
Leukocytes
Clinical Use
INTERCEPT Plasma Product Description
Indications and Contraindications
Viruses
Bacteria
Parasites
Leukocytes
Clinical Use
Customer Letters

Implementation and Use
Overview: Collection & Processing
Range Requirements
Add Amotosalen
UVA Illumination
Amotosalen Reduction
Release Into Inventory
Illuminator & Disposables
Process Overview Video
Data Integration

Contact Us
About Cerus
Legal Info
Privacy Policy

 

© Cerus Corporation. All Rights Reserved.

Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.
Legal Info  |   Privacy Policy